Stefan-Erik von Euw

Director/Board Member at NovaHep AB

Finance

Health Technology

Commercial Services

Profile

Stefan-Erik von Euw is currently a Director at NovaHep AB.
Previously, he was a Director at Recopharma AB and a Managing Partner at Alden Impact Capital AG from 2011 to 2017.

Stefan-Erik von Euw active positions

Companies	Position	Start
NovaHep AB NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden.	Director/Board Member	-

All active positions of Stefan-Erik von Euw

Former positions of Stefan-Erik von Euw

Companies	Position	End
Alden Impact Capital AG Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011.	Private Equity Investor	30/12/2017
Recopharma AB Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden	Director/Board Member	-

See the detail of Stefan-Erik von Euw's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stefan-Erik von Euw's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Alden Impact Capital AG Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011.	Finance
Recopharma AB Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden	Health Technology
NovaHep AB NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden.	Commercial Services

See company connections

Stock Market
Insiders
Stefan-Erik von Euw